Results 81 to 90 of about 435 (140)

Prokinetics in Gastroparesis

Gastroenterology Clinics of North America, 2015
Prokinetic agents are medications that enhance coordinated gastrointestinal motility and transit of content in the gastrointestinal tract, mainly by amplifying and coordinating the gastrointestinal muscular contractions. In addition to dietary therapy, prokinetic therapy should be considered as a means to improve gastric emptying and symptoms of ...
Andres, Acosta, Michael, Camilleri
openaire   +2 more sources

The potential of ghrelin as a prokinetic

Regulatory Peptides, 2009
Ghrelin is a 28 amino-acid peptide discovered in 1999. It is synthesized mainly in endocrine cells of the gastric mucosa and secreted into the blood. Physiological contributions of the peptide in human include probably regulation of growth hormone and of appetite.
Poitras, Pierre, Tomasetto, Catherine
openaire   +2 more sources

Prokinetics in Diabetic Gastroparesis

Current Gastroenterology Reports, 2012
Within the last 50 years, diabetic gastroparesis has become a well recognized complication of type 1 and type 2 diabetes. It is a syndrome characterized by abnormal gastric function, resulting in delayed emptying of the stomach in the absence of any evident mechanical obstruction, predominantly manifested by early satiety, postprandial fullness, nausea,
Reza A, Hejazi, Richard W, McCallum, Irene, Sarosiek   +2 more
openaire   +2 more sources

Effects of Prokinetics on the Digestive Tract

Current Reviews in Clinical and Experimental Pharmacology, 2022
Background: Functional gastrointestinal disorders account for at least a third of visits to gastroenterology clinics. Despite pathophysiological complexity, impaired gut motility may be frequently present in these disorders. Introduction: Prokinetics are a class of drugs that promote gastrointestinal motility, accelerate transit, and potentially ...
Paolo Usai-Satta, Mariantonia Lai, Francesco Oppia, Francesco Cabras   +3 more
openaire   +2 more sources

Diabetic gastropathy and prokinetics

The American Journal of Gastroenterology, 2003
The treatment of diabetic gastropathy, which here refers to a clinical syndrome of upper GI tract symptoms suggestive of an upper motility disturbance in diabetes whether or not there is delayed gastric emptying, remains suboptimal. New prokinetics and other motility-modifying agents may prove useful, but adequate clinical trials will be required to ...
openaire   +2 more sources

Clinical application of prokinetics

Veterinary Clinics of North America: Equine Practice, 2003
Intestinal stasis or ileus is a significant cause of mortality and morbidity in horses and has been attributed to a variety of causes, including loss of intrinsic or extrinsic electrical activity, incoordination of contractile activity from regional stimuli, and dissociation between electrical and mechanical activity.
openaire   +2 more sources

Use of prokinetics in the preterm infant

Current Opinion in Pediatrics, 2011
Functional gastrointestinal dysmotility is a common condition that affects premature infants. Delay in achievement of full enteral nutrition results in dependence on prolonged parenteral nutrition, predisposing to adverse outcomes. Studies in recent years show apparently conflicting results regarding the use of prokinetic agents in preterm infants ...
Hugh S, Lam, Pak C, Ng
openaire   +2 more sources

Prokinetic agents in the surgical patient

The American Journal of Surgery, 1999
Surgeons may be confronted by several conditions that benefit from therapy with prokinetic agents. Prokinetic agents enhance contractile force, coordinate contractile activity, and accelerate transit in the gastrointestinal tract. Although some of these drugs may also have antiemetic effects, these are not the focus of this review.
J S, Thompson, E M, Quigley
openaire   +2 more sources

Prokinetics Influence the Pharmacokinetics of Rabeprazole

Digestion, 2008
<i>Background:</i> Proton pump inhibitors (PPIs) are unstable at a low PH. Accelerated transfer of PPIs to the upper small intestine may influence the pharmacokinetics of PPIs. <i>Aim:</i> To see if concomitant use of mosapride citrate with rabeprazole sodium influences the pharmacokinetics of the PPI. <i>Methods:</i>
Katsuhito, Arai, Yoshiaki, Takeuchi, Hideki, Watanabe, Atsushi, Tsukurimichi, Naoki, Uchida, Michio, Imawari   +5 more
openaire   +2 more sources

Cisapride: A Gastrointestinal Prokinetic Drug

Annals of Pharmacotherapy, 1994
OBJECTIVE: To summarize the pharmacology, pharmacokinetics, efficacy, and safety of cisapride, and to evaluate its potential therapeutic role. DATA SOURCES: A computerized search of the MEDLINE database was used to identify English ...
J A, Barone, L M, Jessen, J L, Colaizzi, R H, Bierman   +3 more
openaire   +2 more sources